Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Montinutra

Explore full profile

Produces high value bioactive products from forest industry side streams

Raisio, FinlandFounded 2018Biotech & Life Sciences
Valuation $10–25M Last recorded · 2023
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Montinutra and the history behind them.

About Montinutra

Montinutra, which is newly branded as Boreal Bioproducts®, is a Finnish B2B company founded in 2018, operating at the intersection of the bioeconomy and circular economy. The firm is focused on upcycling underutilized side streams from the forest industry, such as sawdust and bark, into high-value, sustainable biochemicals. This approach directly challenges the chemical and cosmetics industries' reliance on fossil-based raw materials. The company's current CEO is Jaakko Pajunen, who brought over 15 years of experience in business development and the circular economy, including a role as Development Director at Lassila & Tikanoja, when he took the helm in January 2022.

The core of Montinutra's operation is a proprietary production process based on pressurized hot water extraction (PHWE). This method avoids the use of chemical solvents, enabling a robust, zero-waste, and cost-effective production of natural fractions with a minimal environmental footprint. By transforming forestry by-products, the company provides a scalable, bio-based alternative to fossil-derived materials without interfering with the food production chain. Their business model centers on creating value from these existing resources, ensuring a steady, year-round supply of certified and renewable feedstock.

The product portfolio, marketed under the Boreal Bioproducts® brand, includes a range of natural, vegan, and biodegradable ingredients. These biochemicals, such as SpruceSugar™ (polysaccharides) and SpruceLigno™ (lignins), serve diverse applications including industrial binders, barrier coatings, dispersants, and personal care products. For the cosmetics sector, the ingredients offer functionalities like film-forming, SPF-boosting, and anti-aging properties. After securing €2 million in a pre-A funding round led by Metsä Spring in late 2023, Montinutra is accelerating its international expansion and the development of an industrial demo plant, which is planned to be operational by 2026. The company's long-term ambition is to achieve an annual revenue of 100 million euros by 2035.

Source: Dealroom company data

At a glance

Founded
2018
Headquarters
Raisio, Finland
Sector
Biotech & Life Sciences

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇫🇮 Finland100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Montinutra on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Montinutra on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.